Autosomal Recessive Non-Syndromic Deafness: Is AAV Gene Therapy a Real Chance?
Autosomal Recessive Non-Syndromic Deafness: Is AAV Gene Therapy a Real Chance?
About this item
Full title
Author / Creator
Publisher
Basel: MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
Basel: MDPI AG
Subjects
More information
Scope and Contents
Contents
The etiology of sensorineural hearing loss is heavily influenced by genetic mutations, with approximately 80% of cases attributed to genetic causes and only 20% to environmental factors. Over 100 non-syndromic deafness genes have been identified in humans thus far. In non-syndromic sensorineural hearing impairment, around 75–85% of cases follow an...
Alternative Titles
Full title
Autosomal Recessive Non-Syndromic Deafness: Is AAV Gene Therapy a Real Chance?
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_851f9cd5e7f743e9badd5ae2705b5fc9
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_851f9cd5e7f743e9badd5ae2705b5fc9
Other Identifiers
ISSN
2039-4349,2039-4330
E-ISSN
2039-4349
DOI
10.3390/audiolres14020022
